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The role that biomaterials play in the clinical treatment of damaged organs and tissues is changing.
While biomaterials used in permanent medical devices were required to passively take over the function
of a damaged tissue in the long term, current biomaterials are expected to trigger and harness the self-
regenerative potential of the body in situ and then to degrade, the foundation of regenerative medicine.
To meet these different requirements, it is imperative to fully understand the interactions biomaterials
have with biological systems, in space and in time. This knowledge will lead to a better understanding of
the regenerative capabilities of biomaterials aiding their design with improved functionalities (e.g.
biocompatibility, bioactivity). Proteins play a pivotal role in the interaction between biomaterials and
cells or tissues. Protein adsorption on the material surface is the very first event of this interaction, which
is determinant for the subsequent processes of cell growth, differentiation, and extracellular matrix
formation. Against this background, the aim of the current review is to provide insight in the current
knowledge of the role of proteins in cellebiomaterial and tissueebiomaterial interactions. In particular,
the focus is on proteomics studies, mainly using mass spectrometry, and the knowledge they have
generated on protein adsorption of biomaterials, protein production by cells cultured on materials, safety
and efficacy of new materials based on nanoparticles and the analysis of extracellular matrices and
extracellular matrixederived products. In the outlook, the potential and limitations of this approach are
discussed and mass spectrometry imaging is presented as a powerful technique that complements
existing mass spectrometry techniques by providing spatial molecular information about the material-
biological system interactions.
© 2018 Elsevier Ltd. All rights reserved.1. Introduction
Implants based on natural or synthetic materials have a long
history of use as replacements for damaged, malfunctioning organs
and tissues [1,2]. Initially the extent of use of (predominantly nat-
ural) materials was driven by their availability. However, failure
often occurred as a consequence of adverse body responses, in-
fections, and in general the lack of understanding of the in-
teractions between the body and these materials [3,4]. Since the
start of the 20th century, increasing insights in materials science as
well as molecular and cell biology have emerged into the field of.nl (P. Habibovic).biomaterials science. Biomaterials, in particular in the form of
medical devices, have improved quality of life of many patients
with dental implants, artificial joints, ocular lenses and vascular
stents, being thewell-known examples.With themain role of these
devices to replace the damaged tissue and passively take over its
function, their selection and manufacturing are predominantly
based on mimicking the chemical and physical properties of the
natural tissue, while causing minimal foreign body response.
With the emergence of tissue engineering in the late 1980s and
1990s, the expected role of materials for biomedical applications
started to shift from replacement of damaged and diseased body
parts to stimulation of desired biological responses in the body,
with the final aim to initiate inherent regenerativemechanisms and
regain natural function [1]. To achieve this goal, biomaterials are
used as (temporary) carriers of cells and/or biological molecules.
Fig. 1. Schematic illustration showing a proteomic approach based on two-DE gel
electrophoresis and subsequent MS analysis, adapted from Ref. [16]; two-DE gel re-
duces the complexity by resolving the proteins by charge (isoelectric point, pI) in the
first dimension and further separating proteins by mass in the second dimension on
gels. Then the protein samples can be consequently analysed by MS.
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use of INFUSE Bone Graft, a construct based on a degradable
collagen sponge carrier and recombinant human bone morphoge-
netic protein 2 (rhBMP2), developed to treat large, critical-sized
bone defects, which do not heal spontaneously. This and other
constructs based on rhBMPs were developed as an alternative to
autologous bone grafts, the availability of which is limited, for
multiple clinical applications such as spinal fusion, internal fixation
of fractures, and filling of bone voids [5]. Nevertheless, the clinical
use of products based on BMPs is still associated with a number of
side effects, heterotopic bone formation being among the most
important ones [6,7]. This side effect is associated with supra-
physiological amounts of the growth factor used in clinical practice,
as well as with insufficient control over its release kinetics from the
carrier material, a result of an incomplete understanding of the
interaction between the protein and the carrier material.
In general, despite the promise of conventional tissue engi-
neering approaches, few products based on materials combined
with cells and/or growth factors have actually reached patients.
While unsatisfying performance and adverse side effects are
important reasons for the limited clinical translation of this tech-
nology, complex regulatory pathways and high costs are at least as
important. As a result, the focus is now shifting to the design and
development of smart, instructive biomaterials that are able to
attract and accumulate relevant cells and growth factors in situ, to
initiate and stimulate the process of regenerationwithout the need
for pre-operative addition of cells or biologics. Such instructive
materials, often based on polymers, ceramics and their combina-
tions, are expected to fully degrade inside the body after fulfilling
the role for which they were initially designed [8e13].
Clearly, with this changing role of biomaterials from passive to
instructive, and even responsive, in time and space, the need for
exactly understanding the biomaterials' interactions with biolog-
ical systems is of utmost importance. This comprehension of
cellematerial and tissueematerial interactions is not only impor-
tant to satisfy scientific curiosity, but it is a prerequisite for our
ability to design new, improved biomaterials. Moreover, currently
the pace at which biomaterials reach the clinic is slow. One of the
major bottlenecks is that there is a poor correlation between the
in vitro and in vivo performance of biomaterials [14,15]. Knowledge
of the global cellular and molecular events that occur when bio-
materials interact with a complex biological system can lead to a
better prediction on materials behaviour going from an in vitro to
an in vivo setting, and ultimately to a better understanding of why
certain materials succeed in the clinic where others fail. Thus,
improved knowledge of tissue-material interactions will tremen-
dously aid future material design and ultimately faster clinical
development of biomaterials [16e19].
Understanding the interactions at the biomaterial-biological
interface is, however, not a trivial task. Various material proper-
ties, including chemical composition, structural characteristics at
various length scales and mechanical properties, have been shown
to act as potential cues instructing and directing biological pro-
cesses [20e23]. Because these properties are often interconnected,
it is difficult to make a direct correlation between individual
properties and biological responses.
A particularly powerful tool to describe the interactions be-
tween cells/tissues andmaterials is by protein actions, since protein
adsorption on the material surface is one of the very first events in
this interaction [24]. Proteins adsorbed to the material surface
facilitate and control cell adhesion and the subsequent cellular
events, including cell proliferation and differentiation [25]. The
quantity and properties of the adsorbed proteins are highly
dependent on the material (surface) properties [26e28]. In turn,
the first layer of attached proteins determines the formation andcontent of subsequent protein layers, affecting the fate of the ma-
terial itself, in terms of e.g. regenerative capacity [29], biocompat-
ibility [30], and degradation [31]. Various methods exist to study
the behaviour of proteins, including their transcription, post-
translational modifications, conformation, spliced variants or intra-
and extracellular spatial distributions. While methods such as
Western blot and immunoassays are suitable for determining
protein behaviour on biomaterials in a limited number of samples
and for a limited number of proteins, large-scale characterisation
methods are preferred to provide broader protein content of a cell,
tissue or organism. Proteomics based onmass spectrometry (MS), is
a large-scale study of proteins that reside within a cell, organism or
system [32,33]. Such studies are particularly interesting to obtain a
more global and integrated view of biology by studying the pro-
teome of a biological environment, rather than each protein indi-
vidually [34]. When coupled to other techniques, such as e.g. two-
dimensional gel electrophoresis (2-DE), complex protein samples
can be investigated with high sensitivity and reproducibility
especially when proteins have been previously labelled with
spectrally resolvable fluorophore agents (CyDyes) [35e39] (Fig. 1).
Moreover, with appropriate sample preparation such as the
depletion of highly abundant proteins from complex biological
samples [36], or multidimensional phase separation based on
liquid chromatography coupled to MS (also referred to as shotgun
proteomics) [40,41], this technology has even allowed for the
detection of proteins present in small amounts. However, reliable
MS data depend on many other biological and technical variables
such as sample type, sample collection methods, and method
optimisation and instrumentation [36,42].
To complement a previously published review that provides an
overview of various high-throughput and high-content techniques
used to study biomaterials in regenerative medicine, including
various proteomics techniques [43], the aim of the current paper is
to describe the knowledge gained on cellebiomaterial and
tissueebiomaterial interactions by studying proteins, with special
emphasis onMS-based studies. The objective is to describe the type
of knowledge that is gained from using proteomic approaches and
discuss how these methods can potentially affect the development
of new biomaterials. In the first part, the focus is on the adsorption
of proteins on material surfaces. The importance of understanding
the process of protein adsorption and the effects of various material
properties on this process is described. In the second part, the
Fig. 2. Schematic illustration of protein adsorption on the surface of biomaterials
leading to thrombus formation. Reprinted, with permission from Oleschuk et al. [64].
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contact with the material are covered. The third part is dedicated to
the study of proteins in interactions between nanoparticles/
nanoparticle-based materials and biological systems. The fourth
section focuses on the use of proteomics to understand extracel-
lular matrix (ECM) and ECM-derived biomaterials. Finally, the
outlook provides a summary of the existing knowledge and dis-
cusses the limitations of the existing MS techniques and the pos-
sibilities of new MS-based techniques to further advance the
knowledge of cellematerial and tissueematerial interactions.
2.Protein adsorption on biomaterials
Protein adsorption on a biomaterial surface is the first event that
occurs in any biological system [44]. Understanding the behaviour
of an interfacial protein thus offers a good opportunity to improve
surface design for implants used for various medical applications.
However, there are many factors that affect protein adsorption such
as the chemical and physical properties of the biomaterial, and
external factors of the surrounding solvent system such as pH,
temperature, ionic strength, and concentration of different protein
species in a buffer solution [45]. The nature of the proteins them-
selves (e.g. size and structure) also affect the adsorption behaviour.
For example, small proteins such as lysozyme, b-lactoglobulin, or a-
chymotrypsin are known to have a relatively low tendency for
structural modification upon adsorption. In contrast, intermediate-
sized proteins like albumin, transferrin, and immunoglobulins
possess a higher ability to undergo conformational reorientation
once in contact with a surface, with in general, larger proteins
binding more strongly to a surface compared to smaller proteins
[46]. Moreover, often these proteins can expel pre-adsorbed pro-
teins. Thus, protein adsorption is a complex and dynamic process
often accomplished with an overlap of transport and repulsion that
is affected bymany internal and external factors [46]. In this section
the effects of protein adsorption on the biological response and
strategies that aim to understand and modulate the protein adhe-
sion properties of materials are discussed.
2.1. Effects of protein adsorption on the biological response
Upon implantation of biomaterials, protein adsorption on the
surface occurs within seconds [44,47,48], whereas circulating cells
usually do not have direct access to the material surface. Therefore,
the body's response to the implants are determined mostly by the
extent and nature of the initial protein adsorption [47,48]. Many
studies have shed light on how the adsorbed proteins influence the
inflammatory response [49], in particular with regard to the role of
abundant plasma proteins including albumin [50,51], immuno-
globulins [52] and fibrinogen [53,54]. For example, studies have
shown that albumin-coated surfaces reduce the acute inflamma-
tory response as they prevent the attraction of inflammatory cells
[47]. Fibrinogen-coated surfaces, on the other hand, have shown to
play a significant role in inducing inflammatory responses [47,55].
In one such study a polystyrene surface coated with fibrinogen
facilitated platelet adhesion and activation, which subsequently led
to the development of surface-induced thrombosis [56] (Fig. 2).
Adsorbed immunoglobulin has been shown to significantly prevent
cell distribution and in addition, to reduce metabolic activity of
attached cells [57].
Understanding the role abundant plasma proteins play in
modulating biological responses can also be used to steer a specific
reaction by coating the surface of biomaterials with proteins before
implantation. For instance, surface coated with collagen and
fibronectin can promote cell adhesion and cell spreading
[45,58,59]. Coating a surface with albumin can prevent otherpathological proteins to be adsorbed on the same surface, which
can lead to a lower inflammatory response [45].
2.2. Prevention of nonspecific protein binding
While control over protein adsorption to surfaces of bio-
materials is important in determining the cellular response to these
materials, preventing nonspecific protein binding is of equal
importance. The general thought is that proteins adsorb in mono-
layers, and they cannot stack on top of each other. However, it is
also known that already adsorbed proteins can be displaced or
replaced by other proteins, a phenomenon known as the Vroman
effect [46]. Often, proteins with relatively small molecular weight
are replaced by larger proteins on the surfaces of biomaterials.
These large proteins are unable to preserve their native structure,
which could eventually lead to unfavourable reactions such as
blood clots or fibrous capsules forming around the implant [60]. In
contrast to the consensus that proteins adsorb to surfaces of bio-
materials in monolayers, the ability of proteins to adsorb on top of
each other was shown in a study by Holmberg and Hou [61], who
analysed the adsorption of albumin and fibrinogen onto poly(-
ethylene terephthalate) (PET) and glass surfaces by selective
labelling. The results revealed that fibrinogen could adhere onto a
pre-adsorbed albumin layer, but at the same time, pre-adsorbed
albumin reduced the amount of adsorbed fibrinogen. The authors
concluded that protein replacement was not the major process
occurring on the surfaces and that the total amount of protein was
higher when the proteins were sequentially exposed to the surface
compared to the conditions where proteins were added simulta-
neously. Using biomaterials that prevent the adsorption of specific
proteins can also be used as a strategy to improve biocompatibility
of implants. For example, Wang et al. [62] showed that proteins like
vitronectin, thrombin, fibrinogen and complement component C3
were adsorbed in significantly lower amounts on hydrogels, which
correlated with a significant lower number of monocytes,
compared to polystyrene culture plates. Also the medium is
important in determining the adsorption effect. For example, Ser-
pooshan et al. [63] utilised label-free liquid chromatography-
tandem mass spectrometry (LC-MS/MS) to characterise proteins
that were adsorbed on collagen type 1 gels upon immersion in
different biological fluids, such as fetal bovine serum, and C57
mouse serum and plasma. After two hours of incubation, the data
indicated that gels yielded several common and unique proteins.
For example, gels immersed in serum had more unique proteins
(e.g., Ighg1, Orm1 and 2, Ambp, and Apoa proteins) than those
incubated in plasma (Igh-VX24 heavy chain V), suggesting that
plasma contains factors that prevent serum proteins to adhere to
the collagen surface. Serum contains plasma but without clotting
factors, which means that proteins might have higher affinity for
the collagen gel surface compared to the plasma environment.
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adsorption
Several recent studies have investigated to which extent protein
adsorption can be controlled by modulating the physicochemical
and structural properties of biomaterials. Specifically, changing the
surface roughness can have a big effect on the layer composition of
the adsorbed proteins. For example, the importance of surface
roughness is demonstrated by the fact that plasma-etched, but not
untreated tissue culture polystyrene supports the expansion of
pluripotent human embryonic stem cells (hESCs). Hammad et al.
[66] used MS to investigate this effect by exposing untreated and
plasma-treated surfaces to a complex mouse embryonic fibroblast-
conditioned cell culture medium. Among 71 proteins identified on
both surfaces, 14 were shown to be uniquely adsorbed on plasma-
etched polystyrene. Further validation using a combinatorial pro-
tein spotting approach showed that a combination of heat shock
protein 90 and heat shock protein 1 promoted adherence of
pluripotent stem cells to the surface.
Apart from surface roughness also the chemical properties of
the biomaterial are important factors in determining the fate of the
implant. Abdallah et al. [67] investigated this by using label-free
liquid chromatography-electrospray ionization-tandem mass
spectrometry (LC-ESI-MS/MS) to measure the proteomic signature
of ECM proteins adsorbed on surfaces of widely used biomaterials
including several types of hydrogels, metals, and polymers. While
this study confirmed that both chemical and structural properties
of the biomaterials affect the content of the adsorbed protein layer,
a particularly interesting finding was that amination of poly(-
methylmetacrylate) (PMMA) and of poly(D, L lactic acid) (PDLLA)
allowed the adsorption of important basal lamina proteins laminins
(a, b), nidogen-1, and keratin 5, which in turn resulted in improved
adhesion and proliferation of epithelial cells. In contrast, phos-
phorylation of PDLLA and PMMA decreased the protein content of
laminins (a, b), nidogen-1, and keratin 5 (Fig. 3).
Chemical modifications on titanium (Ti), commonly used in
dental and orthopaedic applications owing to its mechanical
properties and biocompatibility, have also been evaluated for their
effect on protein adsorption [68]. For example, the properties of theFig. 3. Influence of chemical surface modifications on protein adsorption. Atomic force
microscopy images showing amination (middle row) and phosphorylation (bottom
row) of PMMA and PDLLA surfaces, which affected the adsorption of basal lamina
proteins [67]. Reprinted, with permission from Abdallah et al. [67].surface of Ti dental implants, consisting of titanium dioxide (TiO2),
are essential for osseointegration, which is defined by a direct
contact of bone with the implan surface. This is partially attributed
to the fact that TiO2 attracts proteins that are related to bone like
proteoglycans, ECM proteins, enzymes, and growth factors [69] as
well as proteins related to cell adhesion, transport, coagulation,
immune response and cytokines [65]. However, in some, instead of
direct bone-to-implant contact, a fibrous layer may be formed on
the surface of these implant, eventually leading to implant failure
[70]. In an attempt to improve osteointegration of Ti implants,
Oughlis et al. [70] studied Ti implants coated with poly(sodium
styrene sulfonate), using uncoated Ti as a control. Separation of
eluted proteins by high-resolution 2-DE gel coupled to nanoeLC-
MS/MS exhibited a significantly higher number of proteins adsor-
bed from platelet-rich plasma, leading to improved cell adhesion
on polymer-functionalised Ti compared to control material. Simi-
larly, Romero-Gavilana et al. [15] assessed protein adsorption on
four types of hybrid sol-gel biomaterials based on different ratios of
methyltrimethoxysilane, 3-glycidoxypropyl-trimethoxysilane tet-
raethyl orthosilicate and triethoxyvinylsilane silicates. These ma-
terials have been shown to enhance the bone regenerative capacity
of calcium phosphate (CaP)-based materials by releasing osteoin-
ductive silicon compounds [71]. Using LC-MS/MS they found six
proteins related to complement pathway and acute inflammatory
response that were more abundant on materials with a higher
organic compound content and a more hydrophobic surface, which
correlated with weaker biocompatibility. This data shows that
distinct biomaterials properties such as hydrophobicity can affect
the composition of the adsorbed proteins and determine the
biocompatibility and bioactivity of biomaterials.
Similarly, Yang et al. [72] studied the role of adsorbed proteins
on cell adhesion and cellular protein profile in response to two
materials, nickel titanium (NiTi) alloy and titanium nitride (TiN)
with the aim to evaluate the effect of nickel ion release on endo-
thelial cell function. They found that in the early stage, the ion
release did not affect cell adhesion mediated by the adsorbed
proteins. The same authors used proteomics to examine the mo-
lecular mechanism behind the effect of adsorbed proteins on cell
attachment using uncoated TiN, TiN coated with NiTi and chitosan
films [73]. TiN and NiTi adsorbed significantly higher amounts of
serum proteins related to cell adhesion and growth compared to
chitosan films. The authors identified four mechanisms that
mediated enhanced cell adhesion and proliferation on these ma-
terials; by adsorbed proteins that bound to cell surface receptors, by
inducing the TGF-b signalling pathway, by binding of adhesive
glycoproteins that activate integrins, and lastly, by binding of pro-
teins that regulate actin cytoskeleton organization.
In addition to chemical modifications, materials of the same
chemical nature but differing in their chemical phase have been
evaluated for their biological responses. A known example are CaP-
based ceramics, widely used biomaterials in bone repair and
regeneration owing to their close chemical resemblance to natural
bone mineral. Different chemical phases of CaP impart different
physicochemical properties such as grain size, specific surface area,
and degradation, which in turn affect their in vivo biological per-
formance. For example, when comparing octacalcium phosphate
(OCP) and hydroxyapatite (HA), the former phase, which is more
degradable than HA, was shown to better support bone formation
[74]. In a study focusing on protein adsorption on these materials
using LC-MS/MS, it was shown that more proteins from rat serum
adsorbed on OCP than on HA [75]. Further quantification of target
proteins showed significantly higher levels of apoliprotein E
(ApoE), known to promote osteoblast differentiation in vitro, on
OCP compared to HA. In contrast, complement 3 (C3), a crucial
component of the innate immune system [76] and involved in
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compared to OCP. These differences in protein adsorption were
suggested to be a reason for the different biological performance of
OCP and HA in terms of bone formation. For this study, multiple
reaction monitoring (MRM) analysis was used, which consists of
two stages of mass selection of the precursor ion, yielding a very
specific and sensitive measurement of the target analyte in com-
plex protein mixtures [78].
In a number of studies, proteomics-based analyses were used to
study the biocompatibility of haemodialysis membranes [79]. For
example, Urbani et al. [80] and Pieroni et al. [81], used label-free
shotgun proteomic analyses to compare protein adsorption pro-
files between two types of membranes used in the extracorporeal
haemodialysis systems. Protein analysis and coagulation profiles
were performed on elutes from patients undergoing dialysis, either
by using the cellulose triacetate or the synthetic polymer
polysulfone-based helixone membrane. The results of these studies
revealed differentially expressed proteins on the two membranes,
with low abundant proteins predominantly found on the helixone
membrane, and high-abundant plasma proteinsmore concentrated
on the cellulose triacetate membrane. Furthermore, it was
demonstrated that the coagulation biological pathways are
modulated during dialysis. The differences between the two
membranes were shown not to be patient-dependent, but rather
membrane material properties dependent, with differences lying
partially in their hydrophilicity.
The described approaches of investigating the effect of different
physicochemical properties of biomaterials on protein modulation
offer an improved understanding of the factors that influence
protein adsorption on the surface and eventually cell behaviour.
However, elucidating the exact mechanisms of how proteins are
adsorbed on biomaterials is far from complete. Accurate, reliable,
and high-throughput/high-content measurements are needed to
further understand the protein adsorption phenomena, in combi-
nation with comprehensive characterisation of the material prop-
erties. An elegant example of a study in which protein adsorption
was used as a tool to design new materials in search for optimised
stem cell microenvironments is the study by Mei et al. [82]. Here,
high-throughput polymer synthesis was coupled to a fast material-
protein-cell interaction assay, revealing that the chemical diversity
of the materials led to different fibronectin adsorption and cell
adhesion. The observed effect was attributed to the capacity of the
polymers to induce different conformations of the adsorbed
fibronectin.
3. Protein production by cells on biomaterials
Following the initial events of protein adsorption on the
biomaterial surface, cells that are in contact with the biomaterial
can attach, proliferate and differentiate. These processes are asso-
ciated with unique protein production profiles, and describing
these profiles is useful in understanding and steering cell-material
interactions. Few examples of studies exist in which high-content
protein analyses were successfully used to describe such processes
in relation to physical, chemical or structural properties of
biomaterials.
For example, in an effort to understand the biological effects of
surface topography on cell behaviour, Kim et al. [27], determined
protein production of osteosarcoma MG-63 cells cultured on Ti
surfaces. Smooth (S), grit-blasted and acid-etched (SMA), and a
surface coated with a thin layer of hydroxyapatite (HA) were used
for cell culture, followed by two-dimensional gel electrophoresis
and matrix assisted laser desorption ionization time of flight mass
spectrometry (MALDI-ToF-MS) analysis. A lower proliferation rate
was observed for cells cultured on rougher, SMA and HA-coatedsurfaces, compared to the S surface. Furthermore, SMA surfaces
exhibited upregulation of protocadherin-b3 precursor, kinase insert
domain receptor, fibroblast growth factor receptor-3, and insulin-
like growth factor I compared to S surface, whereas HA surface,
compared to S surface, showed upregulation of adhesion kinase,
collagen a-1(I) chain precursor, collagen type XI a2, and cadherin-
11. All these proteins are known for their role in osteoblast adhe-
sion, proliferation, differentiation and cellecell contact. These
findings demonstrated that different surface modifications of tita-
nium triggered the production of different osteogenic proteins,
which may explain, or even predict the clinical behaviour of these
materials.
To unravel the mechanism behind the effect of nanosized sur-
face structure with different organisation levels on cell fate, Kant-
awong et al. [83] studied the differentiation of osteoprogenitor cells
towards osteoblasts on controlled disordered nanopit topographies
on poly(caprolactone) films by employing differential in-gel elec-
trophoresis (DIGE) and dimethyl-labelling proteomics. The results
showed differences in the expression of proteins by the progenitor
cells cultured on different surfaces, which resulted in the identifi-
cation of the extracellular signal-regulated kinase (ERK1/2)
pathway as the main pathway involved in the process of cell dif-
ferentiation. This study elegantly demonstrated that examining
protein expression and secretion profiles by cells can be useful in
describing the correlation between individual material surface
properties and biological responses to such materials.
In another study, Henrionnet et al. [84] used a label-free LC-
MALDI technique to perform relative quantification of secreted
proteins in tissue-engineered cartilage constructs, consisting of
humanmesenchymal stem cells (hMSCs) undergoing chondrogenic
differentiation inside collagen-based scaffolds. This study
emphasised the potential power of secretome analysis as a non-
invasive testing/validation tool for the quality of such tissue-
engineered constructs, but could also be used as an in vitro
biomaterial evaluation tool.
Zhang et al. [85] investigated the interactions between natural
HA ceramic, derived from porcine bones, and bonemarrow-derived
mouse MSCs by combining miRNA, transcriptomics and proteomics
analyses, the latter labeling the samples with 8-plex iTRAQTM and
employing 2D strong cationic exchange/reversed phase liquid
chromatography matrix-assisted laser desorption/ionization-
tandem mass spectrometry (SCX/RP-HPLC-ESI-MS/MS). This study
delivered important insights in the regulation of mRNA protein
pairs by a set of miRNAs in five different differentiation-related
pathways. Furthermore, the study confirmed the role of the
ERK1/2 and JNK MAPK pathways in the osteogenic differentiation
of mMSCs, upon culture on the HA ceramic.
In a follow up study [86], the natural HA ceramic from the
previous study was compared to a synthetic HA ceramic in a similar
experimental set-up. Proteomics analysis following the culture of
MSCs on the two ceramics revealed that the pathways associated
with cell adhesion, proliferation and differentiation were regulated
on both ceramic types, whereas the specific pathways related to
ECMmineralization and angiogenesis were solely supported on the
natural ceramic. The differences in the behaviour of cells were
attributed to the differences between the two ceramic types, with
the natural HA, but not synthetic HA, containing carbonate and
hydrogen phosphate groups, and showing magnesium release and
a more pronounced calcium release. Furthermore, the crystal size
and the crystallinity of the natural ceramic were higher than that of
its synthetic counterpart.
Taken together, although still limited in numbers, these studies
demonstrate that the proteomics is a useful tool to describe the
behaviour of cells on biomaterial surfaces, which, if combined with
appropriate material design, can deliver insights in the relationship
Fig. 4. Protein adsorption and uptake by macrophages of nanoparticles depend on the
degree of poly(ethylene glycol) (PEG) surface modifications, a process known as
“PEGylation”. Higher PEG-density resulted in less protein adsorption and less efficient
macrophage uptake. Low PEG-density modified nanoparticles led to lower protein
adsorption and higher serum dependant macrophage uptake. Reprinted, with
permission from Walkey et al. [94].
Z. Othman et al. / Biomaterials 167 (2018) 191e204196between material properties and a biological response. In turn, this
knowledge can be used as an important input parameter for the
design of new biomaterials with specific bioactivity.
4. Proteomics to study safety and efficacy of nanomaterials
and nanomaterials-based composites
While the number of studies inwhich proteomics has been used
to correlate the properties of materials to their biological perfor-
mance is limited, such techniques are more prevalent for exam-
ining the biosafety and efficacy of nanomaterials, including
nanoparticles. Due to their unique chemical and physical proper-
ties, nanoparticles represent one of the most promising tools for
targeted drug delivery. However, a deeper understanding of the
complex dynamics after their in vivo administration is required.
Yang et al. [87] used proteomic approaches (by ESI MS/MS) to un-
derstand the difference in response between diseased (liver
tumour cells, HepG2) and liver normal cells (CCL-13) upon chitosan
nanoparticle exposure. The authors identified 6 unique proteins
involved in cell growth, differentiation and cycle regulation that
were upregulated in HepG2 cells, but not in CCL-13 cells. These 6
proteins related to the PI3K/AKT1/mTOR pathway, which is
involved in metastasis and proliferation of cancer cells [87].
Proteomics can also be a useful tool in understanding the effect
of shape and size on the biological effect of nanoparticles [88,89].
This was elegantly demonstrated by Xu et al. [90], who monitored
the proteome in osteoblast cells incubated with various nano-sized
HA particles. Interestingly, they found that cells treated with
spherical nano HA showed a higher migration rate compared to
cells incubated with needle-shaped nano HA.
The in vivo stability, biodistribution and fate of nanoparticles has
been found to be highly dependent on the formation of what is
commonly referred to as the protein corona [63,91]; the sponta-
neous coating of nanoparticles surface with proteins in biological
solutions. The role of this complex and dynamic layer of proteins on
the biological activity of nanoparticles needs to be better under-
stood before nanoparticles can reach their full clinical potential.
Proteomics can be a useful tool to help identify this complex layer
[92]. For example, Landgraf et al. [93] used SDS-PAGE coupled to
label-free proteomic approach to analyse and compare the protein
corona formation on PEGylated gold-iron(II,III) oxide based asym-
metric Janus particles, to spherical PEGylated iron(II,III) oxide
nanoparticles (both NH2-functionalized and non-functionalized).
They observed that spherical NH2-functionalized iron(II,III) oxide
nanoparticles had a higher binding affinity for coagulation factors
compared to the other tested nanoparticles which may induce an
immune response in vivo. Thus, spherical iron(II,III) oxide nano-
particles may be less favourable in drug delivery compared to
functionalized asymmetric Janus particles. Knowledge on protein
corona formation can also be used to functionalise nanoparticle
surfaces to prevent or direct specific corona formation. For
example, it has been found that the PEGylation ratio on the surface
of gold nanoparticles can have a great influence on protein
adsorption quantity and, in addition, the type of adsorbed proteins
[94]. In this same study it was shown that higher PEGylation den-
sity on the gold nanoparticle surface resulted in less adsorbed
proteins which in turn led to a less pronounced uptake by macro-
phages (Fig. 4).
While the above described studies function as examples of
where proteomics can be a useful tool in studying nanoparticle
safety and efficacy, for a more comprehensive overview, the reader
is reffered to other excellent reviews on this topic [95e98].
More recently, nanoparticles have been used in the field of tis-
sue and organ regeneration, by means of incorporating them inside
other functional materials with the aim to enhance the propertiesand bioactivity of these materials. In dentistry, for instance, TiO2
nanoparticles have been shown to increase the mechanical prop-
erties and to contribute to the antimicrobial effect of dental ma-
terials [99]. Gao et al. [100] investigated the early response of
lymph node proteins to intradermal exposure to TiO2 nanoparticles
in mice. By using trypsin-catalyzed 16O/18O labelling in conjunc-
tion with 2D LC-MS/MS, the authors identified 33 differentially
expressed proteins in samples exposed to TiO2 compared to vehicle
particles. These proteins may be involved in immune response, and
lipid and mRNA processing. In another similar study, Armand et al.
[101] used whole proteome analysis to reveal the toxicity mecha-
nism of chronic exposure of A549 epithelial alveolar cells to TiO2
nanoparticles. The results showed a change in abundance of 30
proteins involved in glucose metabolism, trafficking, gene expres-
sion, mitochondrial function, proteasome activity, and DNA damage
response. It was furthermore noted that the cell cycle progression
and proliferation of cells exposed to TiO2 were decreased. Zhao
et al. [102] performed LC-MS/MS analysis of protein changes inMG-
63 osteosarcoma cells that incorporated Stable Isotope Labelling
with Amino Acids in Cell Culture (SILAC), and were cultured on
nanosized HA (nHA) added to poly(etheretherketone) (PEEK), a
widely used polymer in orthopaedic surgery. The majority of
upregulated proteins were involved in processes related to calcium
ions, such as endocrine- and other factor-regulated calcium reab-
sorption, the calcium signalling pathway, calcium ion trans-
membrane transport, and sarcoplasmic reticulum calcium ion
transport. The downregulated proteins were related to RNA pro-
cesses such as spliceosome, the mRNA surveillance pathway, RNA
transport, RNA splicing, and mRNA 30-end processing. This study
revealed that incorporating nHA into PEEK increased the bioactivity
of the composites and demonstrated the suitability of a proteomics
approach in monitoring global protein expression. In a similar
approach, Jinling Xu et al. [103] compared protein profile changes in
osteoblasts cultured on HA and HA reinforced with carbon nano-
tubes (CNTs) using isobaric tags for relative and absolute quantifi-
cation (iTRAQ) coupled to 2D LC-MS/MS analysis. The results
revealed higher expression of cytoskeletal proteins, metabolic en-
zymes, signalling, and cell growth proteins in cells cultured on HA
compared to CNT-HA.
These studies demonstrated the utility of proteomics ap-
proaches in evaluating cellular responses to new materials, spe-
cifically those incorporating nanoparticles. The rapid development
of nanotechnology has resulted in the production of many different
types of nanoparticles for various biomedical applications. The
incorporation of nanoparticles into functional biomaterials for
regenerative medicine can enhance the biological performance and
properties of such materials [104]. As MS-based proteomics
Fig. 5. Schematic illustrating the methodology used for preparing cartilage sections, to
allow proteomic analysis. The sections were decellularised by a single freeze/thaw
cycle in hypotonic solution. Method 1 illustrates the extraction of cartilage proteins by
using guanidine-HCL extraction buffer with or without surfactant. Method 2 repre-
sents extraction of decellularised section by in situ trypsin digestion. Method 3 shows
cartilage extraction by surfactant-assisted guanidine-HCl with ultrafiltration. The
sections were collected from different cartilage layers (i.e., superficial, intermediate,
and deep) of different joints and under different physiological conditions. All methods
allowed subsequent qualitative and quantitative proteomic analysis. Reprinted, with
permission from Hsueh et al. [116].
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used as an initial screening tool to compare different new nano-
materials and could become an excellent readout tool to monitor
cellular responses.
5. Proteomics to analyse ECM and ECM-derived products and
their interactions with cells
Various types of instructive biomaterials are currently under
development for use in regenerative medicine applications. Bio-
materials based on (mimics of) ECM are highly promising for their
ability to reconstitute the natural in vivomicroenvironment of cells,
supporting them in accomplishing the process of repair and
regeneration [105]. ECM-based approaches have known several
successes in replacing and treating damaged tissues like tendon,
muscle, heart valves, bone, and cartilage [106,107]. The widespread
use of ECM is related to their structure and protein content, which
are determinant for the performance of ECM in (re)creating the
optimal microenvironment for cells. It is therefore not surprising
that an extensive range of proteomics studies have focused on
describing the exact content of ECM and ECM-derived products.
Understanding this content, and the role of individual proteins in
the matrix, is particularly important since currently, the majority of
ECM-based materials result from a decellularisation process of
natural tissues or organs, which is why they are highly heteroge-
neous and often differ from batch to batch.
Matrigel is probably themost widely used ECM-like biomaterial,
in particular in cancer and stem cell research. Matrigel is composed
of a complex mixture of basement membrane proteins and has the
unique ability to maintain stem cells in the undifferentiated state
[108]. In an attempt to describe its contents, Hughes et al. [109],
analysed and compared standard Matrigel and growth
factorereduced (GFR) Matrigel. GFR Matrigel is derived from
standard Matrigel but reduced in growth factors such as basic
fibroblast growth factor, epidermal growth factor, insulin-like
growth factor 1, transforming growth factor beta, platelet-derived
growth factor, and nerve growth factor. By applying LC-MS after
the two-step ammonium sulphate precipitation and size exclusion
chromography (SEC), the authors were able to identify 1302 pro-
teins in standard Matrigel, of which 480 were unique proteins (i.e.,
not found in GFR Matrigel). On GFR Matrigel, 1246 proteins (424
unique proteins not found in standard Matrigel) were detected.
This approach provided insight into the complex protein content
within different formulations of Matrigel, and suggested that,
because of this complexity, replacingMatrigel by a synthetic matrix
will be challenging.
Another ECM-based material that is often used for different ap-
plications including peripheral nerve, spinal cord, skin, and bone
regeneration are keratose-based scaffolds. Keratose is an oxidized
variant of humanhair protein, keratin. Guzman et al. [110] employed
MS to identify the exact protein content of keratose after oxidizing
the cortical and cuticle parts of human hair. The MS results of the
keratose extraction identified the abundance of cortical keratin
species of type 1 (K31, 33A, 33B, 34, and 35) and type II (K81, 83, 85,
and 86). In addition, K1 epithelial keratin was detected at very low
concentrations. Characterisation of keratin and keratose, and un-
derstanding the role of their constituents is important for further
optimisation of products based on these ECMs. For example, it has
been shown that the manipulation of molecular weight, oxidative
state, and effective crosslink density of these products may affect
their degradation rate in vivo [6], however, these changes may also
affect their protein content, in turn possibly changing the regener-
ative potential of the keratose-based products.
While several ECM products are commercially available,
extensive research efforts are expended to develop new ECMs, bydecellularising tissues and organs. Proteomics is a valuable tool to
analyse the results of decellularisation and validate new protocols,
supporting the development of new materials. For example, pro-
teomics techniques have been used to demonstrate the effective-
ness of decellularisation protocols of heart and lung tissues
[111e113]. In contrast to these protocols, the existingmethods were
shown not to be suitable for removing chondrocytes from cartilage
tissue, without modifying the composition of ECM, consisting of
high-abundance proteins like collagens, proteoglycans, and hyal-
uronic acid, as well as low-abundance proteins including cartilage
oligomeric matrix protein, fibromodulin, and fibronectin [114,115].
To address this challenge, Hsueh et al. [116] developed a novel
cartilage ECM extraction method that allows subsequent prote-
omics analysis, demonstrating that MS-based proteomics can be
used as a reliable tool for localising proteins within a cartilage
matrix. The authors combined the conventional guanidine-HCl
extraction method with in situ trypsin digestion, to preserve the
ECM content and enable the analysis of the spatial distribution of
proteins within the matrix, which may be used to study the pro-
gression of osteoarthritis (Fig. 5). The study demonstrated that the
surface layers exhibited a more pronounced presence of both
unique and abundant ECM proteins compared to deeper cartilage
layers, while the deeper layers exclusively exhibited a few proteins
including aggrecan core protein, fibroblast growth factor-binding
protein 2 (FGFP2), and phospholipase A2 (PA2GA).
Calle et al. [117], employed LC-MS/MS to evaluate the protein
content of lung ECM prepared using two methods of decellular-
isation and compared it with native tissue. They showed that by
gentle decellularisation, proteins such as laminins, proteoglycans,
and other basement membrane and ECM-associated proteins were
preserved at a level closer to that of native tissue than when
harsher conditions were used (i.e. CHAPs method, 0.4% solution of
pH> 12). This study aided the optimisation of the decellularisation
protocol, aiming at maximal preservation of the protein content,
and in particular the growth factors content of the tissue, which is
essential for maintaining bioactivity of the ECM.
In another study investigating the protein content of rat lung
tissue [118], LC-MS/MS analysis was used to compare the native and
decellularised ECM by examining both soluble and insoluble pro-
teins and by using stable isotope-labelled peptides for endogenous
protein quantification. The protocol used in this study, which was
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indicated that structural collagen was predominately found in the
insoluble protein fraction in decellularised tissue and that the
decellularisation method eliminated 98% of the intracellular
proteins.
While the global overview of the protein content of an ECMmay
be sufficient in some applications, in other cases, monitoring the
presence of a specific protein or growth factor is of great impor-
tance. In a study by Nienhuijs et al. [119], the biological content of
COLLOSS®E, an equine derived ECM consisting of a collagenous
matrix and a growth factor mixture, was investigated using ELISA,
Western blot, and LC-MS/MS. The rationale behind this study was
to identify which growth factors are present in COLLOSS®E and
relate these to its osteoinductive capability. Interestingly, ELISA
identified BMP-2 and BMP-7, which were not detected by either MS
or Western blot. LC-MS/MS identified a number of growth factors,
including TGF-b1, TGF-b2, and BMP-3. These findings were vali-
dated by the Western blot analysis except for BMP-3, which could
not be identified using this method. It was furthermore suggested
that COLLOSS®E possibly contains more proteins that were not
detectable by the three techniques used. This study shows that,
while useful in determining the global composition of ECM and
related proteins, there is still room for improvement when it comes
to identification of individual, low-abundance proteins, even when
different (high-throughput and high-content) techniques are used.
Some of these technical issues can be overcome by for example,
sample fractioning to reduce sample complexity, frequent pre-
clearing, and using high-mass resolution instrumentation to iden-
tify low-abundant proteins [36].
While a majority of studies on ECM-like biomaterials focused on
understanding the content of different matrices, several studies
exist in which the interactions between cells and ECMs were
investigated to identify which components of the materials are
responsible for specific biological responses. For example, Hughes
and coworkers [120] performed a proteomic analysis employing
strong anion and strong cation exchange chromatography and SDS-
PAGE, to identify the composition of five commonly used ECMs, and
Matrigel. The authors identified fibronectin as being critical for
maintaining pluripotent H9 and CA1 hESCs in an undifferentiated
state, which is a step forward to designing new, and better defined
ECM products.
Similarly, Soteriou et al. [121] employed proteomics to charac-
terise and catalogue a range of ECMs that are supportive for self-
renewal of hESCs. This study further revealed that it is a balance
between structural network properties and molecular composition
of ECM and protein-to-protein interactions that determines the
maintenance of pluripotency of hESCs.
In another study [122], LC-MS/MS was used to analyse the
contents of three types of ECMs generated from decellularised
undifferentiated ESC aggregates, spontaneously differentiated
embryoid bodies and the ESC-derived neural progenitor cell ag-
gregates. Following this analysis, the capacities of these different
ECMs to support proliferation and neural differentiation of mESCs
and human induced pluripotent stem cells (hIPSCs) were investi-
gated. Interestingly, the cells cultured on different ECMs showed
distinct cellular phenotypes, with undifferentiated ESC-derived
ECM supporting the maintenance of pluripotency and the neural
progenitor cell derived ECM supporting neural differentiation.
The studies described in this section exemplify the possibilities
that the proteomic approaches offer for obtaining a deeper un-
derstanding of the composition of ECM and ECM-derived products,
as well as for getting insight in interactions between such products
and cells. This knowledge is essential for assessing the suitability of
ECM products for various biomedical applications. Furthermore,
the complete understanding of the contents of matrices such asMatrigel and the role/relevance of each of its constituents in the
biological response to this matrix, will pave the way towards suc-
cessful synthesis of fully synthetic ECM products.
6. Discussion
In this review, we focused on the current knowledge of the role
proteins play in interactions between biomaterials used in
biomedical applications and biological systems. The aim was to
understand how this knowledge can be used for developing new
biomaterials with improved performance and for a faster and more
efficient translation of the research results to the clinic. Emphasis
was placed on high-throughput and high-content methods for
protein analyses, mainly MS, as such methods are particularly
useful for obtaining a complete understanding of these
interactions.
Not surprisingly, the majority of studies investigated the
adsorption of proteins on biomaterials surfaces, the very first event
in the interaction between biomaterials and a biological environ-
ment. The ability to control the process of protein adsorption, either
by facilitating selective binding of desired proteins, or by prevent-
ing binding of undesired ones, is determinant for the fate of the
material upon implantation, and its performance. This does not
only concern the inflammatory response of the body to the mate-
rial, but also the processes leading to tissue repair and regeneration,
such as cell adhesion, proliferation and differentiation. Neverthe-
less, very few studies exist in which biomaterials design was
actually used to control protein adsorption and consequent extra-
cellular environment [82]. A vast majority of studies is still at the
stage of identifying proteins adsorbed to the existing biomaterials,
and describing the process of adsorption. This concerns both the
materials already used in the clinic, such as membranes for dialysis
[80,81], Ti implants widely used in orthopaedics [69,123] and
extensively applied polymers such as PMMA and PDLLA [67], to
new biomaterials designs. All these studies have shown that both
the environmental effects, as well as the properties of the bio-
materials themselves, such as chemical composition, topography,
surface charge, etc. have an influence on (selective) adsorption of
proteins from biological fluids. Nevertheless, because of a large
variety in materials and experimental set-ups used, it is difficult to
make a direct comparison among different studies, and to define
the correlation between biomaterial properties and protein
adsorption.
Similar to protein adsorption, different material properties were
also shown to affect the interactions between cells and biomaterials
at the protein level. These studies often focused on understanding
the fate of cells in contact with biomaterials surfaces, it terms of
differentiation and ECM production. Some of these studies have
delivered important insights in, for example, pathways leading to
nanotopography-triggered differentiation of osteoprogenitor cells
into the osteogenic lineage [83]. Interestingly, this specific study
made use of carefully designed materials, without immediate
relevance for the clinical use, and was performed in a highly
controlled experimental set-up. This shows that, in order to get
mechanistic insights, one may need to use a bottom-up research
approach starting with model materials, with highly controlled
properties and then progress to other functional materials, to test
whether similar mechanism are also valid in a more complex
environment.
Proteomic approaches were also used in studies focusing on
understanding safety and efficacy of nanoparticles. Such studies
have shown that proteomics analyses were useful in describing
protein corona and have delivered important insights in global
biological responses to nanoparticles, including immune response,
cell cycle and cell proliferation, apoptosis, and cellular adhesion. It
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will further increase in the future, leavingmuch space for MS-based
proteomics techniques to be used to study their long-term perfor-
mance as well.
At least as important as the design of functional implant bio-
materials and nanoparticles for regenerative medicine is the
rational design of (synthetic) alternatives to ECM products like
Matrigel, which, owing to their natural origin, often suffer from
batch-to-batch variability. This in turn can tremendously affect
their performance in (re)creating cellular microenvironments, e.g.
in organoids, which are increasingly important for regenerative
medicine applications. MS-based techniques have been shown to
be particularly useful in identifying the contents of ECM and ECM-
derived products [109,110] as well as to develop new methods for
developing ECM products, e.g. by evaluating the efficacy of decel-
lularisation procedures [117,118]. Furthermore, few elegant studies
have shown the effect of the ECM constituents on cell behaviour
[121], which is a step forward in the design of synthetic ECM
alternatives.
Although this review proves that proteomic techniques have
vastly contributed to the existing knowledge of interaction be-
tween biomaterials and cells/tissues, it remains difficult to draw
general conclusions regarding the effects of biomaterial properties
on protein adsorption or production, for several reasons. First, the
process of protein adsorption and subsequent process of cell
attachment, differentiation, and ECM formation are affected not by
one, but by several properties of a material. In most functional,
clinically used materials, such properties are intertwined, meaning
that it is difficult to change one property without affecting the
others. In other words, from a biomaterials perspective, it is very
difficult to parameterise individual properties in order to get
deeper insights into their correlation with a biological response.
Second, most studies are performed on a limited set of (new) ma-
terials, the properties or the clinical performance of which are not
(yet) fully known. As a result, such studies remain observational
rather than mechanistic, describing differentially adsorbed or
secreted proteins on surface one versus surface two, but not giving
a biological meaning to this interaction. Finally, since techniques for
proteomic analyses are also evolving, no consensus exists yet
regarding the best method to study proteins on biomaterials,
making it difficult to make comparisons among individual studies.
For example, the majority of studies discussed in this review have
employed data-dependent acquisition (DDA) methods
[101,124,125]. DDA uses knowledge obtained during the acquisition
to decidewhatMS1 peptide precursors to subject for fragmentation
(MS/MS) in the collision cell. Data-independent acquisition (DIA),
in contrast, performs predefined MS/MS fragmentation and data
collection regardless of sample content, which allows for more
sensitive and accurate protein quantification compared to DDA
[126].
To overcome the existing challenges, and obtain a better un-
derstanding of cell-material and tissue-material interactions that
can aid the design of new biomaterials and their more effective
translation to the clinic, changes in experimental designs are
required. For example, a thorough characterisation of as many
properties of the tested materials as possible would enable a better
comparison among individual studies. In this context, using
benchmark materials as controls in studies where new materials
are investigated would be useful in relating the observed effect to
the final clinical performance. Furthermore, to be able to establish
better property-function relationships, it is important to invest in
methods that allow decoupling of individual properties of func-
tional biomaterials [127]. In a few recent elegant reviews and
studies, parameterisation of individual material properties coupled
with a description of the genomics, transcriptomics, miRNAsequencing and proteomics landscape of their biological effects,
was suggested as a useful tool to understand interactions of bio-
materials with a biological system [43,85,95,128]. Only when such
tools become routinely used in the biomaterials research, will the
field get full benefit from the results of proteomic studies. It is
furthermore important that the implementation of this tool is done
in close collaborations with people advancing the proteomics, and
other eomics techniques, to identify the best option for answering
individual research questions.
Regardless of the exact application, the use of MS-based prote-
omics to study biomaterialecell interactions requires expertise in
sample preparation and analysis as well as data processing, to
ensure that reliable and meaningful results are obtained. Further-
more, it is important to understand the limitations and the pitfalls
of each of these steps as well as of the specific MS technique when
designing the experiments [36]. Clearly, MS has the potential to be
much more broadly exploited as a means to obtain a more
comprehensive understanding of cellebiomaterial and
tissueebiomaterial interactions, serving as input for the design of
new biomaterials and their more rapid implementation in the
clinic.
7. Outlook: possibilities of mass spectrometry imaging (MSI)
in understanding interactions between biomaterials and
biological systems
Among various technological advancements in the field of
proteomics, mass spectrometry imaging (MSI) (Fig. 6) will be
highlighted here as a method that offers new possibilities for a
better understanding of interactions between biomaterials and
biological systems, that go beyond state of the art. With MSI, mass
spectrometry data is acquired from thin sample sections in a
spatially resolved manner. Images that represent the distribution of
the analytes within the sample are then generated [129]. MSI can
offer spatial molecular information at submicrometer level and
reveal specific zonal molecular profiles that cannot be studied by
conventional histological methods, most of them targeted. MSI
technology is able to assess complex molecular mixtures in cells
and tissues with high chemical specificity, allowing simultaneous
analysis of a variety of molecular species in awidemass range, from
small metabolites to large macromolecules such as proteins.
Further structural assessment of compounds, employs high mass
accuracy by FT-ICR or orbitrap technology and MS/MS fragmenta-
tion analysis [130].
Among the different MSI ionisation technologies, secondary ion
mass spectrometry (SIMS) and MALDI are probably the most
applicable to the field of biomaterials. With SIMS, detectable ions
are typically limited to a narrow mass range of only a few hundred
Daltons but can achieve a spatial resolution down to 100 nm with
the capabilities recently offered [131]. Cluster ion sources (e.g.,
C60 þ and Bi3þ) have effectively extended this mass range limit to
~2 kDa [132]. The majority of the studies have focused on drugs,
lipids, and elemental distribution in the field of surface material
characterisation. For example, time-of-flight (ToF)-SIMS has been
used to describe lipid profiles of stem cells after chondrogenic in-
duction as well under different oxygen tensions in order to char-
acterise markers of cartilage formation [133]. Using ToF-SIMS,
Henss et al. spatially resolved the calcium and collagen distribution
in bone to assess the quality of the interface of bone implants with a
lateral resolution up to 1 mm [134]. The method has been also
employed to study HA formation at the interface between bone and
Ti implants [135]. Although ToF-SIMS images contain a large array
of data related to the distribution of chemical species on a surface,
processing these data to obtain chemical information is not trivial.
As a result, multivariate statistical methods have proven to be
Fig. 6. Principle of mass spectrometry imaging (MSI). MS images are acquired by sampling a regularly spaced grid on a thin tissue section (A); the square delineating a measurement
region in panel A is shown enlarged in panel B. Each measurement spot yields a mass spectrum (C), which allows the visualisation of single mass-to-charge ratios (m/z) (D). As the
sample stays intact, coregistration of the sample histology with the MSI images is possible (D) Reprinted, with permission from Addie et al. [129].
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ToF-SIMS coupled to multivariate analysis, in particular, principal
component analysis, to characterise adsorbed protein films on
surfaces of biomaterials such as mica, poly(tetrafluoroethylene),
and siliconwafer [137]. The interpretation of the spectra of proteins
such as fibronectin, collagen, and three fibronectinecollagen mix-
tures, adsorbed on smooth silicon substrate has been possible
following this workflow [138]. The use of ToF-SIMS with other
methods, such as Raman spectroscopy, and in combination with
multivariate analysis, permits identifying the fate decisions of in-
dividual cells with location specificity. This combination enables
the characterisation of surface chemistry on biomaterial surfaces,
which is critical for understanding the biointerfacial interactions
thatmodulate cell response [139]. Asmentioned above, the study of
proteins and peptides with ToF-SIMS is challenging. Recent work
from our group has shown the capabilities of tandem matrix-
enhanced (ME)-SIMS for de novo sequencing of endogenous pep-
tides from rat pituitary gland tissue. As such, ME-SIMS has over-
come one of the biggest disadvantages of SIMS analysis by
providing the ability to detect biomolecules at high spatial reso-
lution, now including peptides [140].
Compared to SIMS, MALDI imaging can be used for analysing
peptides and proteins up to ~100 kDa [141]. In this approach, tissue/
material sections are covered with a matrix (typically a small
organic acid) for extracting molecules from the specimen and
allowing desorption/ionisation for further analysis in the mass
spectrometer. For the ionisation process, the laser ablates the ma-
trix layer, while the underlying specimen remains intact and thus
allowing histological examination after the MS measurement. The
matrix absorbs the laser energy and transfers the analytes to the
gas phase. The specimen is then raster-scanned (with spatial res-
olutions down to ~3 mm nowadays [142e144]), generating a mass
spectrum for each measured spot [132]. Key parameters to obtain
high spatial resolution images are mainly 1) the choice of matrix
and its application (i. e. choosing an appropriate matrix for analytes
of interest and homogeneity when applied to the tissues) and 2) the
laser spot size [144]. In the field of biomaterials, MALDI imaging has
been employed in combination with gel electrophoresis and thin-
layer chromatography to compare the biological adsorption and
lipid and protein diffusion occurring with expanded poly(tetra-
fluorethylene) (ePTFE) and thermoplastic poly(urethanes) (TPU),both used for blood vessel reconstruction [145]. This study
demonstrated an interaction between biological and graft mate-
rials, and provided insights into polymer changes as early as 10min
after in vivo exposure.
The technology typically used for protein MSI, is a ToF mass
spectrometer equipped with a micro-channel plate (MCP) detector,
which is not well-suited to the detection of high m/z ions. Lower
mass ions can saturate the detector leading to even lower detection
efficiencies for higher-mass ions. The use of other detectors or
specific sample preparation methods with organic solvents, Triton
X-100 or ferulic acid, improves the detection of higher-mass pro-
teins (up to 135 kDa) since they are not efficiently solubilised in the
matrix solution and consequently, are not extracted from the tissue
[101]. In situ enzymatic digestion can as well overcome the diffi-
culties of intact protein analysis. This method consists of depositing
trypsin solution onto a sample surface, which digests the proteins
into peptides that can then be analysed [146]. This is especially
relevant to assess the protein content of areas rich in ECM given its
complex nature. Nevertheless, the tissue ion suppression and the
lack of analyte separation, yield a very limited number of proteins
identified in each position. Different combinations of enzymes can
be used in order to improve the unravelling of the proteome. For
example, hydrogel discs as carriers for the enzyme have been
employed, thus allowing the digestion to take place directly on
discrete tissue areas, preserving the relationship between molec-
ular information and tissue architecture to analyse mineralised and
non-mineralised areas of skin biopsies [147]. High resolution and
accurate mass (HRAM) MALDI Orbitrap, combined with DDA tan-
dem MS analysis, enables the division of entire m/z into multiple
segments of m/z sub-ranges for MS interrogation. As a result, the
complexity of molecular species from tissue samples and the het-
erogeneity of the distribution and variation of intensities of m/z
peaks are greatly decreased. By carefully optimising the experi-
mental conditions such as the dynamic exclusion, the multiplex-
DDA-MSI approach demonstrates better performance with
broader precursor coverage, less biased MS/MS scans towards high
abundance molecules and improved quality of tandem mass
spectra for low intensity molecular species [148].
The majority of MS methods described so far are performed in
vacuum conditions, which can be challenging for some samples.
Desorption electrospray ionisation (DESI) is an ambient MS
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surface and the desorbed molecules are collected and detected
within the mass spectrometer. While this method has proven to be
successful in analysing small molecules, it has been shown to be
more challenging to adapt the technique for the analysis of proteins
[149]. Another ambient technique, liquid extraction surface anal-
ysis (LESA), extracts analytes directly from a surface (0.4e1.0mm
diameter) via the maintenance of a liquid/surface microjunction,
which is the limiting factor in terms of lateral resolution. Rao et al.
[150] have employed both methods coupled with in situ surface
tryptic digestion to identify protein species from a material surface
such as Permanox. This work presents a promising proof of concept
for the use of ambient MS in the rapid and automated analysis of
surface proteins [150]. The possibility of coupling a LC analytic
separation step to the LESA platform, thus adding another dimen-
sion for peptide separation, could overcome some of the challenges
presented by MSI and increase the number of protein identifica-
tions. Finally, it has been recently shown that atmospheric pressure
MALDI-MSI enables the same tissue section to be first analysed by
MSI, to identify regions of interest that exhibit distinct molecular
signatures, followed by localized proteomics analysis using laser
capture microdissection isolation and LC-MS/MS, thereby
increasing tremendously the number of identifications [151].
The examples described in this section clearly demonstrate that
MSI is potentially a highly valuable technique, which can bring new
insights in the material-biological system interactions. Neverthe-
less, this technique is still far from routine use in the biomaterials
research because of the specific sample preparation and treatment
it requires, which is not always possible to perform on commonly
studied and used biomaterials. Moreover, the throughput of this
technique is low, and only a small number of samples can be
studied in a reasonable amount of time, in contrast to other, more
conventional proteomics techniques.
8. Conclusions
Taken together, this review has shown that the analysis of
proteins is a highly valuable tool for understanding the interactions
between biomaterials and biological systems. High-throughput and
high-content methods, such as MS-based proteomics, have the
potential to accelerate and advance our understanding of these
interactions, despite technical challenges that need to be
addressed. Furthermore, it is imperative to couple protein analyses
to thorough material characterisation, to obtain fundamental in-
sights in propertyefunction relationships. Finally, novel techniques,
such as MSI, will complement these insights by providing spatial
molecular information about the interactions between materials
and biological systems.
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